Add like
Add dislike
Add to saved papers

[Results of endovascular treatment of patients with type C and D lesions of the aortoiliac segment according to the TASC II classification].

Presented herein are the results of endovascular interventions carried out in patients with occlusive lesions of the terminal portion of the aorta and iliac arteries (types C and D according to the TASC II classification). The study comprised a total of 45 subjects with type C and D lesions. The technical success rate in the group of patients with type C lesions amounted to 100% and in the group of those with type D lesions to 92.8%. One-year primary patency of iliac arteries after the endovascular intervention was assessed in 40 patients and amounted to 100% for type C lesions and to 92.8% for type D lesions. The obtained findings are strongly suggestive of a possibility of extending the indications for endovascular surgical interventions in management of patients with type C and D lesions, which makes it possible to achieve good immediate and remote results. This type of treatment may be regarded as a method of choice before further considering feasibility of an open surgical intervention.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app